Vancouver, B.C. and Boston, MA, April 26, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) is providing the following update on the...
Read More
Vancouver, B.C. and Boston, MA, April 19, 2018 – Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announces that, further to its press releases...
Read More
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive...
Read More
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive...
Read More
Vancouver, B.C. and Boston, MA, March 8, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the closing of a...
Read More
Vancouver, B.C. and Boston, MA, March 7, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today that the Company expects the...
Read More
Vancouver, B.C. and Boston, MA, March 1, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the offering of a...
Read More
Vancouver, B.C. and Boston, MA, February 26, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today the Company has hired Pam...
Read More
Vancouver, B.C. and Boston, MA, February 15, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the closing of a...
Read More
Vancouver, B.C. and Boston, MA, February 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today that the lead investigator on...
Read More
